🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)
China flag China · Delayed Price · Currency is CNY
29.13
-1.26 (-4.15%)
At close: Nov 20, 2026

SHA:603102 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
113.33128.43139.31169.07137.84148.04
Depreciation & Amortization
45.8845.8841.1737.5633.1223.76
Other Amortization
1.731.73----
Loss (Gain) From Sale of Assets
---0.14-0.06-0.270
Asset Writedown & Restructuring Costs
0.010.010.010.345.664.22
Loss (Gain) From Sale of Investments
-1.05-1.05-1.26-1.11-0.42-
Provision & Write-off of Bad Debts
0.30.31.260.140.371
Other Operating Activities
-39.375.02-11.59-9.8-15.11-0.41
Change in Accounts Receivable
-0.72-0.72-52.14-8.93-22.86-10.4
Change in Inventory
-6.9-6.96.416.92-41-31.59
Change in Accounts Payable
14.514.54.31-10.1955.8234.21
Operating Cash Flow
126.53186.02127.65193.85152.91169.15
Operating Cash Flow Growth
-26.86%45.73%-34.15%26.78%-9.60%12.77%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-37.49-55.66-94.92-96.52-51.54-124.55
Sale of Property, Plant & Equipment
0.010.020.280.250.610
Cash Acquisitions
--58.41----
Divestitures
---0.090.08-
Investment in Securities
--10----
Other Investing Activities
10.5914.3614.7515.58.911.71
Investing Cash Flow
-26.89-109.7-79.89-80.68-41.95-122.83

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--2.1-2.18-1.37-2.62-1.29
Lease Payments
-2.1-2.1-2.18-1.37-2.62-1.29
Net Debt Issued (Repaid)
-2.1-2.1-2.18-1.37-2.62-1.29
Issuance of Common Stock
----616.06-
Repurchase of Common Stock
-30.03-30.03-0.61-38.25--
Common Dividends Paid
-46.71-46.71-47.23-38.4-32-14.4
Other Financing Activities
26.214.75---13.56-
Financing Cash Flow
-52.62-74.08-50.02-78.02567.87-15.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-8.82-3.131.260.796.67-1.15
Net Cash Flow
38.21-0.88-135.95685.529.48

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
89.04130.3632.7397.33101.3644.6
Free Cash Flow Growth
-9.18%298.29%-66.37%-3.98%127.25%-61.56%
Free Cash Flow Margin
9.00%14.31%4.08%11.17%13.98%6.74%
Free Cash Flow Per Share
1.432.080.511.521.620.93
Levered Free Cash Flow
46.1967.58-1.2750.3352.3314.38
Unlevered Free Cash Flow
47.0267.77-1.2250.3952.4114.48
Free Cash Flow After Leases
86.94128.2730.5595.9698.7443.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
58.5759.1758.864.3841.5155.42
Change in Working Capital
5.75.7-41.11-2.28-8.29-7.45